The synthesis and structure-activity relationships of 4-aryl-3-aminoquinolin-2-ones: A new class of calcium-dependent, large conductance, potassium (maxi-K) channel openers targeted for post-stroke neuroprotection

被引:130
作者
Hewawasam, P
Fan, WH
Knipe, J
Moon, SL
Boissard, CG
Gribkoff, VK
Starrett, JE
机构
[1] Bristol Myers Squibb Pharmaceut Res Inst, Dept Chem, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Pharmaceut Res Inst, Dept Neurosci, Wallingford, CT 06492 USA
[3] Bristol Myers Squibb Pharmaceut Res Inst, Dept Metab & Pharmacokinet, Wallingford, CT 06492 USA
关键词
D O I
10.1016/S0960-894X(02)00240-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 4-aryl-3-aminoquinoline-2-one derivatives was synthesized and evaluated as activators of the cloned maxi-K channel mSlo (hSlo) expressed in Xenopus laevis oocytes using electrophysiological methods. A brain penetrable activator of maxi-K channels was identified and shown to be significantly active in the MCAO model of stroke. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1779 / 1783
页数:5
相关论文
共 36 条
[31]   Neuroprotective effects of adenosine in cerebral ischemia, window of opportunity [J].
Sweeney, MI .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (02) :207-217
[32]   FOCAL CEREBRAL-ISCHEMIA IN THE RAT .1. DESCRIPTION OF TECHNIQUE AND EARLY NEUROPATHOLOGICAL CONSEQUENCES FOLLOWING MIDDLE CEREBRAL-ARTERY OCCLUSION [J].
TAMURA, A ;
GRAHAM, DI ;
MCCULLOCH, J ;
TEASDALE, GM .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1981, 1 (01) :53-60
[33]  
WALSH DA, 1980, SYNTHESIS-STUTTGART, P677
[34]  
Wilding TJ, 1996, MOL PHARMACOL, V49, P540
[35]   Incidence and occurrence of total (first-ever and recurrent) stroke [J].
Williams, GR ;
Jiang, JG ;
Matchar, DB ;
Samsa, GP .
STROKE, 1999, 30 (12) :2523-2528
[36]  
XU XP, 1994, J PHARMACOL EXP THER, V271, P362